Yayın:
The role of immunotherapy in lung cancer: Actual scenery

Sadeleştirilmiş öğe sayfası
dc.contributor.authorHüseynli, Aydan
dc.contributor.authorErtekın, Sevinc Nursena
dc.contributor.authorAKALIN ÇİFTÇİ, GÜLŞEN
dc.contributor.authorGülşen Akalın Çiftçi
dc.contributor.orcid0000-0001-8328-4157
dc.contributor.orcid0000-0002-9104-5313
dc.contributor.orcid0009-0003-7311-6434
dc.contributor.orcid0000-0001-9535-2508
dc.date.accessioned2025-11-13T12:05:49Z
dc.date.issued2023-04-24
dc.identifier.doihttps://doi.org/10.55971/ejls.1267898
dc.identifier.endpage51
dc.identifier.issn2822-5333
dc.identifier.issue1
dc.identifier.openalexW4366813062
dc.identifier.startpage45
dc.identifier.urihttps://hdl.handle.net/11421/8948
dc.identifier.urihttps://doi.org/10.55971/ejls.1267898
dc.identifier.volume2
dc.language.isoen
dc.relation.ispartofEuropean Journal of Life Sciences
dc.rightsopenAccess
dc.subjectPembrolizumab
dc.subjectNivolumab
dc.subjectDurvalumab
dc.subjectMedicine
dc.subjectAtezolizumab
dc.subjectImmunotherapy
dc.subjectLung cancer
dc.subjectCancer
dc.subjectRadiation therapy
dc.subjectOncology
dc.subjectCancer immunotherapy
dc.subjectAvelumab
dc.subjectInternal medicine
dc.subjectBlockade
dc.subjectImmunology
dc.subject.sdg3
dc.titleThe role of immunotherapy in lung cancer: Actual scenery
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5035031280
local.authorid.openalexA5104593709
local.authorid.openalexA5059753642

Dosyalar

Koleksiyonlar

Publications